Centrally Acting Therapies for Irritable Bowel Syndrome

Madhusudan Grover, Douglas A. Drossman

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Irritable bowel syndrome (IBS) and other functional gastrointestinal (GI) disorders typically defy traditional diagnostic methods based on structural abnormalities, and has led to the emergence of the discipline of neurogastroenterology or the study of the "brain-gut axis," which is based on dysregulation of neuroenteric pathways as a key pathophysiological feature of IBS. Centrally acting treatments can influence these pathways and improve the clinical manifestations of pain and bowel dysfunction associated with this disorder. To successfully implement these treatment strategies, it is important to recognize their dual effects on brain and gut, understanding the nature and severity of the GI symptoms and their psychosocial concomitants, and applying them within the context of the patient's understanding of their value.

Original languageEnglish (US)
Pages (from-to)183-206
Number of pages24
JournalGastroenterology Clinics of North America
Volume40
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

Irritable Bowel Syndrome
Critical Pathways
Gastrointestinal Diseases
Brain
Pain
Therapeutics

Keywords

  • Antidepressants
  • Behavioral treatments
  • Irritable bowel syndrome
  • Psychotropic agents
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Centrally Acting Therapies for Irritable Bowel Syndrome. / Grover, Madhusudan; Drossman, Douglas A.

In: Gastroenterology Clinics of North America, Vol. 40, No. 1, 03.2011, p. 183-206.

Research output: Contribution to journalArticle

@article{a8aaedbf350a43a9a69d405c04bc2e3e,
title = "Centrally Acting Therapies for Irritable Bowel Syndrome",
abstract = "Irritable bowel syndrome (IBS) and other functional gastrointestinal (GI) disorders typically defy traditional diagnostic methods based on structural abnormalities, and has led to the emergence of the discipline of neurogastroenterology or the study of the {"}brain-gut axis,{"} which is based on dysregulation of neuroenteric pathways as a key pathophysiological feature of IBS. Centrally acting treatments can influence these pathways and improve the clinical manifestations of pain and bowel dysfunction associated with this disorder. To successfully implement these treatment strategies, it is important to recognize their dual effects on brain and gut, understanding the nature and severity of the GI symptoms and their psychosocial concomitants, and applying them within the context of the patient's understanding of their value.",
keywords = "Antidepressants, Behavioral treatments, Irritable bowel syndrome, Psychotropic agents, Treatment",
author = "Madhusudan Grover and Drossman, {Douglas A.}",
year = "2011",
month = "3",
doi = "10.1016/j.gtc.2010.12.003",
language = "English (US)",
volume = "40",
pages = "183--206",
journal = "Gastroenterology Clinics of North America",
issn = "0889-8553",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Centrally Acting Therapies for Irritable Bowel Syndrome

AU - Grover, Madhusudan

AU - Drossman, Douglas A.

PY - 2011/3

Y1 - 2011/3

N2 - Irritable bowel syndrome (IBS) and other functional gastrointestinal (GI) disorders typically defy traditional diagnostic methods based on structural abnormalities, and has led to the emergence of the discipline of neurogastroenterology or the study of the "brain-gut axis," which is based on dysregulation of neuroenteric pathways as a key pathophysiological feature of IBS. Centrally acting treatments can influence these pathways and improve the clinical manifestations of pain and bowel dysfunction associated with this disorder. To successfully implement these treatment strategies, it is important to recognize their dual effects on brain and gut, understanding the nature and severity of the GI symptoms and their psychosocial concomitants, and applying them within the context of the patient's understanding of their value.

AB - Irritable bowel syndrome (IBS) and other functional gastrointestinal (GI) disorders typically defy traditional diagnostic methods based on structural abnormalities, and has led to the emergence of the discipline of neurogastroenterology or the study of the "brain-gut axis," which is based on dysregulation of neuroenteric pathways as a key pathophysiological feature of IBS. Centrally acting treatments can influence these pathways and improve the clinical manifestations of pain and bowel dysfunction associated with this disorder. To successfully implement these treatment strategies, it is important to recognize their dual effects on brain and gut, understanding the nature and severity of the GI symptoms and their psychosocial concomitants, and applying them within the context of the patient's understanding of their value.

KW - Antidepressants

KW - Behavioral treatments

KW - Irritable bowel syndrome

KW - Psychotropic agents

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=79951562467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951562467&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2010.12.003

DO - 10.1016/j.gtc.2010.12.003

M3 - Article

C2 - 21333907

AN - SCOPUS:79951562467

VL - 40

SP - 183

EP - 206

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

SN - 0889-8553

IS - 1

ER -